With continuous glucose monitoring systems (CGM) become more insurance covered, more affordable and better accuracy, more and more diabetic patients are using glucose CGM because of its great benefits,
IWel Health announces addition of Michael A Friedman, MD, to its Scientific Board. Dr. Friedman is an experienced healthcare leader with a distinguished career in oncology research, regulatory strategy, and public healthcare policy. He served Read more…
Glutalor Medical announces one of its US patent applications related to its glucose CGM (continuous glucose monitoring) technology has been granted. Their patent application ” Dynamic Blood Glucose Data Acquiring Device and Host” was granted Read more…
0 Comments